A conserved matrix epitope based DNA vaccine protects mice against influenza A virus challenge

Antiviral Res. 2012 Jan;93(1):78-85. doi: 10.1016/j.antiviral.2011.10.021. Epub 2011 Nov 9.

Abstract

DNA vaccination represents a unique strategy to overcome the limitations of immunization with conventional vaccines which is restricted by the high variability of influenza viruses. We evaluated the protective efficacy of a plasmid DNA (pDNA), encoding an evolutionarily conserved epitope of viral matrix protein, against the influenza A virus infection. It was found that the mice immunized via the intra-muscular route purely elicited cell mediated immune response to the pDNA, with enhanced level of Th1 cytokines viz. IL-12 and IFNγ production in the stimulated splenocyte supernatant. The cytotoxic T lymphocytes in the spleen of immunized mice significantly lysed the virus-infected MDCK cells. A significant decrease in virus replication was also observed in the lungs of immunized mice and 83% of the mice were protected against the lethal challenge of influenza A viruses. These findings suggest that the plasmid DNA expressing a single matrix epitope may serve as a promising vaccine candidate to provide effective immunity in the susceptible (mouse) population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CHO Cells
  • Cell Line
  • Chick Embryo
  • Cricetinae
  • Dogs
  • Epitopes / genetics
  • Epitopes / immunology*
  • Epitopes / isolation & purification
  • Influenza A virus / genetics
  • Influenza A virus / immunology*
  • Influenza Vaccines* / genetics
  • Influenza Vaccines* / immunology
  • Mice
  • Mice, Inbred BALB C
  • Orthomyxoviridae Infections / mortality
  • Orthomyxoviridae Infections / prevention & control*
  • Plasmids
  • Spleen / cytology
  • Spleen / immunology
  • T-Lymphocytes, Cytotoxic / immunology
  • Vaccines, DNA* / immunology
  • Viral Matrix Proteins / genetics
  • Viral Matrix Proteins / immunology*

Substances

  • Epitopes
  • Influenza Vaccines
  • M1 protein, Influenza A virus
  • Vaccines, DNA
  • Viral Matrix Proteins